Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Spironolactone plus finasteride reduces hirsutism more effectively.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Hormones and genes affect hair growth and male baldness.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.